The Association for Professionals in Infection Control and Epidemiology and the Society for Healthcare Epidemiology of America have requested $743.7 million in funding for infection prevention programs from the U.S. House of Representatives' Appropriations Subcommittee.
The Appropriations Subcommittee has jurisdiction over HHS. APIC and SHEA submitted a joint testimony to the subcommittee recommending infection prevention program funding for fiscal year 2014. APIC and SHEA made the following funding requests:
• $27.5 million for the Centers for Disease Control and Prevention's National Healthcare Safety Network and the Prevention Epicenters Program.
• $182.2 million for core infectious diseases, including funding for healthcare-associated infections, antimicrobial resistance and CDC's Emerging Infections Program.
• $34 million for the Agency for Healthcare Research and Quality to reduce and prevent HAIs; specifically, $11.6 million in HAI research grants and $22.4 million in HAI contracts including the Comprehensive Unit-based Safety Program.
• $500 million annually for the National Institute of Allergy and Infectious Diseases' antibacterial and related diagnostics efforts by the end of FY 2014. NIAID should invest at least $100 million annually in its new antibiotic-resistance focused clinical trials network, APIC and SHEA wrote.
NQF Endorses Infectious Disease, Neurological, Pulmonary Measures
5 Predictors of Infection From Antibiotic-Resistant Strain of E. Coli
The Appropriations Subcommittee has jurisdiction over HHS. APIC and SHEA submitted a joint testimony to the subcommittee recommending infection prevention program funding for fiscal year 2014. APIC and SHEA made the following funding requests:
• $27.5 million for the Centers for Disease Control and Prevention's National Healthcare Safety Network and the Prevention Epicenters Program.
• $182.2 million for core infectious diseases, including funding for healthcare-associated infections, antimicrobial resistance and CDC's Emerging Infections Program.
• $34 million for the Agency for Healthcare Research and Quality to reduce and prevent HAIs; specifically, $11.6 million in HAI research grants and $22.4 million in HAI contracts including the Comprehensive Unit-based Safety Program.
• $500 million annually for the National Institute of Allergy and Infectious Diseases' antibacterial and related diagnostics efforts by the end of FY 2014. NIAID should invest at least $100 million annually in its new antibiotic-resistance focused clinical trials network, APIC and SHEA wrote.
More Articles on Infection Control:
Infection Control Market Expected to Reach $14B by 2017NQF Endorses Infectious Disease, Neurological, Pulmonary Measures
5 Predictors of Infection From Antibiotic-Resistant Strain of E. Coli
